MEFENAMIC ACID

  • Composition
  • Release form
  • Indication
  • Reception scheme
  • Contraindications
Active ingredient: 1 tablet contains 500 mg of mefenamic acid; excipients: microcrystalline cellulose, potato starch, copovidone, crospovidone, sodium lauryl sulfate, magnesium stearate, colloidal anhydrous silicon dioxide.
There are 10 tablets in a blister, 2 blisters in a pack.
Acute respiratory viral infections and influenza.
• Pain of low and medium intensity: muscle, joint, traumatic, toothache, headaches of various etiologies, postoperative and postpartum pain.
• Primary dysmenorrhea. Dysfunctional menorrhagias, including those caused by the presence of intrauterine contraceptives, in the absence of pelvic organ pathology.
• Inflammatory diseases of the musculoskeletal system: rheumatoid arthritis, rheumatism, ankylosing spondylitis.
Used internally. The medicine should be taken after meals.
Adults and children over 12 years old 250-500 mg 3-4 times a day. If necessary, the daily dose is increased to a maximum of 3000 mg, after achieving a therapeutic effect, the dose is reduced to 1000 mg / day.
Children aged 5 to 12 years are prescribed 250 mg 3-4 times a day. The course of treatment for joint diseases can last from 20 days to 2 months or more. When treating pain syndrome, the course of treatment lasts up to 7 days.
Hypersensitivity to the components of the drug. Bronchospasm, Quincke's edema, rhinitis, bronchial asthma, history of urticaria, which arose after the use of acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs (NSAIDs). Concomitant use of specific COX-2 inhibitors. Peptic ulcer and duodenal ulcer, including a history of inflammatory bowel disease, hematopoietic diseases, severe heart failure, severe liver or kidney dysfunction, gastrointestinal bleeding or perforation caused by taking non-steroidal anti-inflammatory drugs, treatment of pain after coronary artery surgery shunting.
Price information